2View LLC recently introduced the 2View, a container used for transporting and imaging breast specimens while keeping them untouched.

With a 2View, the surgeon oversees placement of the specimen in the container and directs the OR staff to apply just enough retention pressure to hold the specimen in place without distortion.

The container can be used for transport and imaging, and can supply orthogonal views. There is no need to open the 2View, nor to compress or manipulate the specimen. The specimen remains untouched until it is removed from the container in Pathology.

Surgeons who remove breast specimens and send them for mammographic interpretation may worry that compression or manipulation will either interfere with or damage the margins they have excised. Clinical articles have been written which indicate that compression can create false negative margins in some cases (pancake phenomena) or that manipulation of the specimen can create false positive margins by damaging the tissue after excision.

The 2View provides a method for viewing the specimen in multiple orthogonal views without being compressed or manipulated. Once these views are obtained and reviewed, the radiologist can report with confidence back to the surgeon what the margin conditions are. The specimen continues on to pathology in its original condition, giving the pathologist greater confidence in his margin analysis as well.

Related Content

News | Breast Biopsy Systems

July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...

Time July 07, 2021
News | Breast Imaging

January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a ...

Time January 04, 2021
News | Prostate Cancer

According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.

Time August 20, 2019
News | Biopsy Systems

Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radiofrequency (RF) spectroscopy technology.

Time March 29, 2019
Technology | Interventional Radiology

The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.

Time February 20, 2019
News | Prostate Cancer

Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two companies work to improve the way prostate cancer is visualized and detected. Cambridge Consultants is applying deep learning to high-resolution micro-ultrasound imaging to identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. Early results show real promise, according to the companies.

Time February 12, 2019
News | Breast Biopsy Systems

A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology

Time January 17, 2019
Videos | Radiation Oncology

Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St. Louis, Mo., explains his ...

Time November 07, 2018
News | Radiation Oncology

October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to ...

Time October 30, 2018
Technology | Breast Biopsy Systems

Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies.

Time October 03, 2018
Subscribe Now